(April 29, 2021) NY, NY – In a historic move, the Biden Administration announced today its decision to ban menthol cigarettes and flavored cigars. The decision comes after a protracted battle in the courts in which the tobacco industry’s aggressive marketing of menthol cigarettes was challenged by medical and public health organizations, including the American Thoracic Society.
Deborah Winter, PhD of Northwestern University has been awarded the ATS /Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis.
The claim that you don’t have to wear a mask after receiving the COVID-19 vaccine has been circulating on social media and told by conservative media pundits such as Tucker Carlson and Rep. Jim Jordan.
What can you expect at the ATS 2021 International Conference, taking place May 14-19? We’ve gone ahead and identified some “hot topics” for your consideration.
A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes. The studies that the authors examined look at several potential disease mechanisms, and also at the relationship between pollution, respiratory viruses and health disparities.
An article launched today by the Forum of International Respiratory Societies (FIRS), an organization comprised of the world's leading international respiratory societies, including the American Thoracic Society, highlights COVID-19 efficacy and safety and calls for urgent equitable access in all countries.
A new study published online in the Annals of the American Thoracic Society examines if the source of physician payment for a medical opinion influences whether the physician finds that a coal miner has black lung disease. The study is the first to look at this relationship in the workers’ compensation process.
A recent opinion piece in the NY Post ignores evidence supporting the effectiveness of lockdowns.
In support of World TB Day, March 24, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, joins the World Health Organization campaign urging governments to act on the commitments made to end TB.
A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19.
Register today to cover the ATS 2021 International Conference and explore the ATS 2021 program before the May 14 online event launches.
A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.
Pregnant women are at increased risk of severe COVID-19. Also, many women of childbearing age have increased COVID-19 exposure risks, including healthcare providers and other workers providing essential services.
A new paper published online in the Annals of the American Thoracic Society provides a roadmap that critical care clinicians’ professional societies can use to address burnout. While strongly needed prior to the COVID-19 pandemic, the roadmap has taken on even greater urgency due to reports of increasing pandemic-related burnout.
While frozen wind turbines underperformed during the Texas power grid failure, according to the Electric Reliability Council of Texas (ERCOT) around 29,000 megawatts of thermal energy — which is sourced from coal, gas and nuclear plants — were missing from the grid.
The ATS 2021 International Conference is May 14-19 this year. We’re virtual and, therefore, available anywhere you are. Our featured speaker is Dr. Anthony Fauci, who will present at the opening ceremony on Saturday, May 15.
A new paper published online in the Annals of the American Thoracic Society describes a “virtual” recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.
A new study published online in the Annals of the American Thoracic Society examines the recovery of lung function and overall wellness in individuals who had varying degrees of COVID-19 severity. Little is known about lung health following infection with SARS-CoV-2, the virus that causes COVID-19, and whether later respiratory problems, fatigue and ill health are associated with the disease’s initial severity.
The American Thoracic Society opposes the EPA’s final rule on Data Transparency issued in the waning days of the Trump Administration. The final rule, which is the focus of a press conference today, is a continuation of the Trump Administration's persistent attack on the science showing the adverse health effects of environmental pollution. This rule would exclude vital scientific data from future EPA decision-making and make patient confidential information more vulnerable to public disclosure.
The Forum of International Respiratory Societies (FIRS), an organization comprised of the world's leading international respiratory societies, including founding member the American Thoracic Society, calls for urgent access to affordable COVID-19 vaccines globally.
In a new research letter published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, researchers examine whether preprint data on the use of the corticosteroid dexamethasone influenced clinical practice in treating COVID-19 critical care patients throughout Australia.
A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior years in asthma-related emergency department (ED) visits at Boston Children’s Hospital during the spring 2020 COVID-19 surge and lockdown.
This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the ATS is a founding member, is calling on governments, health advocates and non-government organizations to strengthen their response to AIDS and tuberculosis, and to ensure that TB services are maintained throughout their response to COVID-19.
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that causes breathlessness, chronic sputum production and cough. There are 300 million current cases of COPD in the world. COPD is currently the third leading cause of death globally and is highly prevalent in low resource countries. Exposure to tobacco smoke and other inhaled toxic particles and gases are the main risk factors for COPD, although recent research has identified that suboptimal lung growth before and after birth can also increase the risk of COPD later in life.
The latest clinical practice guideline on home oxygen therapy addresses long-term and ambulatory oxygen therapy for adults with chronic obstructive pulmonary disease and interstitial lung disease and includes the most comprehensive review of the evidence of any oxygen guideline to date.
In response to the reports of COVID-19 surges around the country, the Critical Care Societies Collaborative, comprising the American Association of Critical‐Care Nurses, American College of Chest Physicians, the American Thoracic Society and the Society of Critical Care Medicine, released the following statement:
A new study published online in the Annals of the American Thoracic Society reveals how patients hospitalized with severe COVID-19 fared, compared to those hospitalized with severe seasonal influenza. The study is believed to be the first in the U.S. to directly compare clinical features, laboratory results and health outcomes between patients with the two diseases.
Thomas S. Valley, MD, of the University of Michigan has been selected as the first-ever recipient of the ATS/CHEST Foundation Research Grant in Diversity. The focus of the research grant is clinical research that contributes to the understanding of the pathophysiology of treatment of conditions related to pulmonary, critical care, or sleep medicine that disproportionately affects underrepresented minority patient groups.
Peter Jackson, MD, of Virginia Commonwealth University, has been named the first recipient of the CHEST Foundation/ATS Research Grant in COVID and Diversity.
A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19. SARS-CoV-2 is the virus that causes COVID-19. Previous studies on this question have had conflicting results.
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.
New research findings contradict statements linking wearing face masks to carbon dioxide poisoning by trapping CO2. During the COVID-19 pandemic the wearing of face masks has become a highly political issue with some individuals falsely claiming that wearing face masks may be putting people’s health at risk. The study published in the Annals of the American Thoracic Society shows otherwise.
Today, the ATS Research Program announced three research grant opportunities with support from 4DMedical, a global medical technology company with a focus on lung health. With a total grant support of $150,000, each of the three $50,000 grants will fund research in asthma, chronic obstructive pulmonary disorder or COPD, and idiopathic pulmonary fibrosis or IPF.
Today, the leadership of the American Thoracic Society issued the following statement in response to the recent executive order by the Trump Administration: On Sept. 22 the President signed an executive order titled “Combating Race and Sex Stereotyping”, which seeks to censor federal agency education efforts to address racial inequality in America.
Today, on World Lung Day (WLD), the American Thoracic Society is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations to advocate for respiratory health globally and call for more research to prevent, detect and treat respiratory infections.
A new Viewpoint piece published online in the Annals of the American Thoracic Society examines the ways in which COVID-19 disproportionately impacts historically disadvantaged communities of color in the United States, and how baseline inequalities in our health system are amplified by the pandemic. The authors also discuss potential solutions.
The ATS Research Program is pleased to announce a new one-year grant supporting sarcoidosis research. The award by Mallinckrodt Pharmaceuticals provides $50,000 in funding.
Today, the CDC released data from the National Youth Tobacco Survey showing that in 2020, 20 percent of high school students and nearly 5 percent of middle school students used e-cigarettes. Most concerning, the data shows that among youth e-cigarette users, 38.9 percent of high school students and 20 percent of middle school students reported using e-cigarettes on 20 or more of the past 30 days; 22.5 percent of high school users and 9.4 percent of middle school users reported daily use.
The ATS Research Program is pleased to announce the new ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome or ARDS. The award will provide $50,000 in funding for one year.
A new research letter published online in the Annals of the American Thoracic Society examines whether asthma is a significant risk factor for developing COVID-19 that is severe enough to warrant hospitalization and intubation. According to the Centers for Disease Control and Prevention, individuals with asthma are at higher risk for hospitalization and other severe effects from COVID-19, similar to the elevated risk from such health conditions as obesity, hypertension and diabetes.
The American Thoracic Society is alarmed by two federal agency policy actions that may significantly impact our nation’s COVID-19 response. This week, the FDA issued an emergency use authorization (EUA) for the use of convalescent plasma to treat COVID-19 disease. This action was taken despite a lack of adequate evidence demonstrating a clear benefit for most patients. As pulmonary and critical care clinicians and researchers who treat individuals with COVID-19, we are concerned that an EUA for convalescent plasma has the potential to put patients at risk.
The American Thoracic Society (ATS), European Respiratory Society (ERS) and International Society for Environmental Epidemiology (ISEE) are dedicated to improving health around the globe, with ATS and ERS achieving this goal by advancing research, patient care and public health in pulmonary diseases, while ISEE advances research on environment and health.
A subcommittee of the American Thoracic Society Assembly in Sleep and Respiratory Neurobiology has released new clinical practice guidelines to help advise clinicians on the optimal management of patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. Hypercapnia is the buildup of carbon dioxide in the bloodstream.
Nodify Lung™ testing helps reclassify risk of malignancy of nodules by identifying patients with a higher or lower risk than indicated by traditional risk assessment
As a doctor, I didn’t expect to find myself living in a tree at the age of 63, but here I am: 82 feet (25 meters) off the ground in a lovely grove of old cotton wood trees trying to stop construction on an oil pipeline.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right